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Acute exposure to high altitude, which is defined as > 2500 
m above sea level, is well-known to be associated with signifi-
cant alterations to the cardiovascular system, with reductions 
in atmospheric pressure, oxygen pressure resulting in acute 
hypoxia, increased myocardial work, increased epinephrine re-
lease, and increased pulmonary artery pressures.1) However, the 
effects of moderate altitude chronic hypoxia on the cardiovas-
cular system have not been much studied. In general, clinically 
significant changes are difficult to demonstrate at elevations lower 
than 2500 m. High-altitude residents have successfully evolved 
adaptive regulatory mechanisms to survive in a chronic hy-
poxic environment.2) Moreover, it has been suggested that ex-
posure to mild to moderate chronic hypoxia may induce car-
dio-protective properties against various disease states such as 
hypertension or coronary heart disease and result in favorable 
outcomes.2)3) In contrast, a few studies reported important phys-
iological and anatomic features of pulmonary vasculature result-
ing in pulmonary hypertension even in healthy subjects living 
at moderate to high altitude.4)5)
In this issue of the Journal, Espinola-Zavaleta et al.6) report 
the results of their study of one-hundred twenty-seven patients 
with Down syndrome (DS) living in Mexico City to assess the 
prevalence of congenital heart disease and pulmonary hyper-
tension. Mexico City is a capital of Mexico and located in the 
Valley of Mexico, a large valley in the high plateaus at the center 
of Mexico, at an altitude of 2240 m. Moderate altitude is de-
fined as 1500–2500 m above sea level. Therefore, Halla Moun-
tain (1950 m) in Korea is corresponding to moderate altitude 
but Paektu Mountain (2744 m) is at high altitude. In this 
study, the investigators demonstrated somewhat interesting 
features of DS in moderate altitude residents although this 
study could not provide conclusive causal relationship. 
First, the most prevalent congenital anomaly in DS in this study 
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was patent ductus arteriosus, probably related with the mod-
erate altitude of Mexico City as interpreted by the authors. Since 
patent ductus arteriosus closes with high oxygen tension, it is 
possible that a hypoxic environment and postnatal persistence 
of pulmonary hypertension delay closure of ductus arteriosus 
resulting in the high prevalence of patent ductus arteriosus in 
this population. Białkowski et al.7) also reported supportive 
evidences of this first unique feature in this study. Larger ductal 
diameter and higher pulmonary artery pressure were observed 
in patients living at moderate to high altitudes (1500–4200 m) 
than in those at low altitudes (340–700 m).7) 
Second, pulmonary hypertension is not rare (46%) even in 
DS patients without congenital heart defects. People native 
living in a chronic hypoxic environment develop alveolar hy-
poxia, hypoxemia, and polycythemia.4) In the heart and pul-
monary circulation, a delayed postnatal remodeling of the dis-
tal pulmonary arterial branches, increased amount of smooth 
muscle cells and increased pulmonary vascular resistance result-
ing in pulmonary hypertension, right ventricular hypertrophy 
have been reported.4)5) The magnitude of pulmonary hyperten-
sion has been known to increase with the altitude level and the 
degree of exercise.4) Interestingly, this structural change in the 
pulmonary vasculature becomes normal after 2 years of resi-
dence at sea level.8)
In the interpretation of the present study, it is needed to un-
derstand the limitations of this study. In fact, this study was not 
a comparison study not only between DS patients living in mod-
erate altitude and those living in sea level but also between DS 
patients and healthy subjects without DS. Therefore, further 
observation and comparison should be needed to confirm the 
higher prevalence of patent ductus arteriosus or pulmonary 
hypertension in DS patients at moderate altitude. In addition, 
the pathophysiology of pulmonary hypertension without con-
genital heart defects in DS or at moderate altitude should be 
studied in the future. Comprehensive cardiopulmonary hemo-
dynamic evaluation using an exercise stress echocardiogram or 
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cardiac magnetic resonance imaging is warranted in order to de-
tect early changes of exercise-induced pulmonary hypertension 
or to clarify the clinical impact on exercise capacity, right ven-
tricular function, or clinical outcomes.9)10) 
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